Synergistic Activity of the MCL-1 Inhibitor S63845 with Midostaurin in Preclinical Human Models of FLT3-ITD Mutated Acute Myeloid Leukemia (AML)

التفاصيل البيبلوغرافية
العنوان: Synergistic Activity of the MCL-1 Inhibitor S63845 with Midostaurin in Preclinical Human Models of FLT3-ITD Mutated Acute Myeloid Leukemia (AML)
المؤلفون: Alix Derreal, Peter P. Ruvolo, Vinitha M. Kurvilla, Anna Skwarska, Qi Zhang, Michael Andreeff, Sébastien Banquet, Andrew H. Wei, Vivian Ruvolo, Natalia Baran, Paul Panis, Marina Konopleva, Shelley Herbrich, Ensar Halilovic, Donia M Moujalled, Erick Morris
المصدر: Clinical Lymphoma Myeloma and Leukemia. 19:S220-S221
بيانات النشر: Elsevier BV, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Cancer Research, chemistry.chemical_compound, Oncology, chemistry, business.industry, Cancer research, Myeloid leukemia, Medicine, Hematology, Midostaurin, business, Flt3 itd
تدمد: 2152-2650
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f8df0aac7af962996f3b9d31bee5065aTest
https://doi.org/10.1016/j.clml.2019.07.095Test
حقوق: CLOSED
رقم الانضمام: edsair.doi...........f8df0aac7af962996f3b9d31bee5065a
قاعدة البيانات: OpenAIRE